固定的三重组合比马托普罗斯特/布里莫尼丁/蒂莫洛尔与单独给药在玻璃眼:随机临床试验
Lilian F Machado1, Mariana Kawamuro1, André Bando1
1Department of Ophthalmology and Visual Science, Federal University of São Paulo, São Paulo, Brazil.
概括
一种固定的三重组合 (FTC) 青光眼药物显示出与单独药物相似的疗效,但导致高血压增加和生活质量降低. 对于这两种治疗方法的持续性都很低,这凸显了治疗晚期玻璃眼的挑战.
科学领域:
- 眼科医生 眼科 眼科
- 临床药理学 临床药理学
背景情况:
- 青光眼的管理往往需要多种局部低血压剂.
- 固定三重组合 (FTC) 疗法旨在简化治疗方案.
- 评估FTC与单独药物的比较疗效和耐受性对于优化患者护理至关重要.
研究的目的:
- 为了比较固定三重组合 (FTC) 的有效性,耐受性和持久性,比马托普罗斯特/布里莫尼丁/蒂莫洛尔与这些药物的单独管理.
- 评估包括副作用,生活质量 (QoL) 和青光眼患者的坚持在内的二次结果.
主要方法:
- 一项随机临床试验,涉及46名患有开角或闭角玻璃眼的患者,需要多种低血压剂.
- 患者被随机分配,在洗期后每天两次接受FTC或单独的药物.
- 评估包括眼内压力测量,高血压分级,撕裂时间,角膜染色,以及对QOL,眼表面和1,4个月和6个月的坚持的验证问卷.
主要成果:
- 无论是FTC还是单独剂的治疗方案都显著降低了眼内压力,但组之间没有显著差异.
- 在两组中都观察到结膜性高血症恶化和生活质量下降.
- 治疗中断率很高 (63%),主要是由于疾病进展和不耐受性,在6个月后维持治疗的概率为69.6%.
结论:
- 固定的三重组合和单独的药物疗法在降低晚期青光眼的眼内压力方面表现出相似的有效性.
- 这两种治疗方法都与逐渐高血压,生活质量下降和治疗持续时间低相关.
- 这些发现强调了多种局部疗法的局限性,用于长期治疗青光眼.
更多相关视频
06:19Comparison of Three Clinical Stereoscopic Methods for Measuring Binocular Visual Function During Amblyopic Treatment in Unilateral Amblyopia
Published on: September 27, 2024
584
06:19Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
1.8K
相关概念视频
01:27Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
01:28Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
01:11Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
01:25Glaucoma: Overview
1.5K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
01:23Ophthalmic Drug Delivery Systems
95
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
95